Samsung BioLogics management and union representatives resumed negotiations on Monday at the Songdo business site in Incheon, South Korea.

The talks follow a four-day strike that disrupted production processes and highlighted growing labor tensions within the Samsung group's diverse workforce. The dispute centers on wages and personnel issues.

Roughly 2,800 workers participated in the strike [1], representing over half of the company's 5,400 total staff [1]. The industrial action led to the suspension of several production lines. Company officials said the strike is estimated to cause a loss of approximately 640 billion won [1].

Negotiations began at 10 a.m. on Monday as both sides sought a resolution to the impasse. The strike had persisted for four days before the parties returned to the bargaining table.

Separate from the BioLogics dispute, the Samsung Electronics union has seen a decline in its ranks. Membership at the electronics division fell by about 2,000 members [1].

“Roughly 2,800 workers participated in the strike”

The scale of the Samsung BioLogics strike, involving more than 50% of the workforce, demonstrates a significant shift in labor leverage within the company's biotech operations. When coupled with the membership decline at Samsung Electronics, these events suggest a volatile period of restructuring and shifting loyalties across Samsung's industrial divisions.